Insider · CIK 0001823925

Frohlich Tom

Reports to the SEC for 2 companies · WALTHAM, MA

sec.gov

Transactions

Companies

Filings

CIK

0001823925

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-02-12	JBIOJade Biosciences, Inc. · Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+473K sh	—	—	472,500
2026-02-12	JBIOJade Biosciences, Inc.A Award	Director, Chief Executive Officer	AAward	+78.8K sh	—	—	86,331
2025-05-16	JBIOJade Biosciences, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+6,000 sh	$7.40	+$44.4K	6,000
2023-08-11	CHINOOK THERAPEUTICS, INC.Restricted Stock UnitsD Disposition to Issuer	Chief Operating Officer	DDisposition to Issuer	−8,400 sh	—	—	0
2023-08-11	CHINOOK THERAPEUTICS, INC.Restricted Stock UnitsD Disposition to Issuer	Chief Operating Officer	DDisposition to Issuer	−6,801 sh	—	—	0
2023-08-11	CHINOOK THERAPEUTICS, INC.Restricted Stock UnitsD Disposition to Issuer	Chief Operating Officer	DDisposition to Issuer	−16.7K sh	—	—	0
2023-08-11	CHINOOK THERAPEUTICS, INC.Restricted Stock UnitsD Disposition to Issuer	Chief Operating Officer	DDisposition to Issuer	−21K sh	—	—	0
2023-08-11	CHINOOK THERAPEUTICS, INC.D Disposition to Issuer	Chief Operating Officer	DDisposition to Issuer	−151K sh	—	—	0
2023-08-11	CHINOOK THERAPEUTICS, INC.Stock Option (Right to Buy)D Disposition to Issuer	Chief Operating Officer	DDisposition to Issuer	−43.8K sh	$39.58	−$1.74M	0
2023-08-11	CHINOOK THERAPEUTICS, INC.Stock Option (Right to Buy)D Disposition to Issuer	Chief Operating Officer	DDisposition to Issuer	−120K sh	$25.23	−$3.02M	0
2023-08-11	CHINOOK THERAPEUTICS, INC.Stock Option (Right to Buy)D Disposition to Issuer	Chief Operating Officer	DDisposition to Issuer	−60K sh	$24.86	−$1.49M	0
2023-08-11	CHINOOK THERAPEUTICS, INC.Stock Option (Right to Buy)D Disposition to Issuer	Chief Operating Officer	DDisposition to Issuer	−30K sh	$22.41	−$672K	0
2023-08-11	CHINOOK THERAPEUTICS, INC.Stock Option (Right to Buy)D Disposition to Issuer	Chief Operating Officer	DDisposition to Issuer	−100K sh	$27.10	−$2.71M	0
2023-08-11	CHINOOK THERAPEUTICS, INC.Stock Option (Right to Buy)D Disposition to Issuer	Chief Operating Officer	DDisposition to Issuer	−84K sh	$14.73	−$1.24M	0
2023-08-11	CHINOOK THERAPEUTICS, INC.Restricted Stock UnitsD Disposition to Issuer	Chief Operating Officer	DDisposition to Issuer	−13.6K sh	—	—	0
2023-02-10	CHINOOK THERAPEUTICS, INC.S Sale	Chief Operating Officer	SSale	−3,700 sh	$23.75	−$87.9K	150,777
2023-02-10	CHINOOK THERAPEUTICS, INC.Restricted Stock UnitsM Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−6,803 sh	—	—	6,801
2023-02-10	CHINOOK THERAPEUTICS, INC.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+6,803 sh	—	—	154,477
2023-01-31	CHINOOK THERAPEUTICS, INC.Stock Option (Right to Buy)A Award	Chief Operating Officer	AAward	+84K sh	—	—	84,000
2023-01-31	CHINOOK THERAPEUTICS, INC.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+8,333 sh	—	—	152,240
2023-01-31	CHINOOK THERAPEUTICS, INC.S Sale	Chief Operating Officer	SSale	−4,566 sh	$24.68	−$113K	147,674
2023-01-31	CHINOOK THERAPEUTICS, INC.Restricted Stock UnirtM Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−8,333 sh	—	—	16,667
2023-01-31	CHINOOK THERAPEUTICS, INC.Restricted Stock UnitA Award	Chief Operating Officer	AAward	+21K sh	—	—	21,000
2022-12-13	CHINOOK THERAPEUTICS, INC.S Sale	Chief Operating Officer	SSale	−10K sh	$25.00	−$250K	143,907
2022-12-13	CHINOOK THERAPEUTICS, INC.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+10K sh	$0.42	+$4,200	153,907
2022-12-13	CHINOOK THERAPEUTICS, INC.Employee Stock Option (right to buy)M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−10K sh	—	—	43,847
2022-11-07	CHINOOK THERAPEUTICS, INC.S Sale	Chief Operating Officer	SSale	−10K sh	$22.16	−$222K	143,907
2022-11-07	CHINOOK THERAPEUTICS, INC.Employee Stock Option (right to buy)M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−10K sh	—	—	53,847
2022-11-07	CHINOOK THERAPEUTICS, INC.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+10K sh	$0.42	+$4,200	153,907
2022-10-06	CHINOOK THERAPEUTICS, INC.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+13.6K sh	—	—	151,267
2022-10-06	CHINOOK THERAPEUTICS, INC.S Sale	Chief Operating Officer	SSale	−7,360 sh	$19.69	−$145K	143,907
2022-10-06	CHINOOK THERAPEUTICS, INC.Restricted Stock Units (RSU)M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−13.6K sh	—	—	13,581
2022-02-11	CHINOOK THERAPEUTICS, INC.S Sale	Chief Operating Officer	SSale	−3,735 sh	$12.74	−$47.6K	137,685
2022-02-10	CHINOOK THERAPEUTICS, INC.Restricted Stock Units (RSU)M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−6,802 sh	—	—	13,604
2022-02-10	CHINOOK THERAPEUTICS, INC.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+6,801 sh	—	—	141,420
2022-01-31	CHINOOK THERAPEUTICS, INC.Stock Option (right to buy)A Award	Chief Operating Officer	AAward	+100K sh	—	—	100,000
2022-01-31	CHINOOK THERAPEUTICS, INC.Restricted Stock (RSU)(Common Stock)A Award	Chief Operating Officer	AAward	+25K sh	—	—	25,000
2021-11-10	CHINOOK THERAPEUTICS, INC.S Sale	Chief Operating Officer	SSale	−6,230 sh	$15.48	−$96.4K	134,619
2021-11-08	CHINOOK THERAPEUTICS, INC.S Sale	Chief Operating Officer	SSale	−13.8K sh	$15.17	−$209K	140,849
2021-11-05	CHINOOK THERAPEUTICS, INC.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+15K sh	$0.42	+$6,300	174,619
2021-11-05	CHINOOK THERAPEUTICS, INC.S Sale	Chief Operating Officer	SSale	−15K sh	$14.00	−$210K	159,619
2021-11-05	CHINOOK THERAPEUTICS, INC.S Sale	Chief Operating Officer	SSale	−5,000 sh	$14.00	−$70K	154,619
2021-11-05	CHINOOK THERAPEUTICS, INC.Employee Stock Option (right to buy)M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−15K sh	—	—	63,847
2021-10-06	CHINOOK THERAPEUTICS, INC.F Tax Payment	Chief Operating Officer	FTax Payment	−7,359 sh	$12.37	−$91K	159,619
2021-10-06	CHINOOK THERAPEUTICS, INC.Restricted Stock Units (RSU)M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−13.6K sh	—	—	27,163
2021-10-06	CHINOOK THERAPEUTICS, INC.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+13.6K sh	—	—	166,978
2021-09-24	CHINOOK THERAPEUTICS, INC.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+20K sh	$0.42	+$8,400	153,398
2021-09-24	CHINOOK THERAPEUTICS, INC.Employee Stock Option (right to buy)M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−20K sh	—	—	78,847
2021-09-24	CHINOOK THERAPEUTICS, INC.S Sale	Chief Operating Officer	SSale	−20K sh	$13.00	−$260K	133,398
2021-06-07	CHINOOK THERAPEUTICS, INC.Employee Stock Option (Right to Buy)A Award	Chief Operating Officer	AAward	+30K sh	—	—	30,000

Recent filings

Accepted (ET)
Feb 134
Frohlich Tom0001193125-26-052054
SEC(opens sec.gov)
May 194
Frohlich Tom0000950170-25-074496
SEC(opens sec.gov)
Aug 114
Frohlich Tom0001209191-23-045418
SEC(opens sec.gov)
Feb 154
Frohlich Tom0001209191-23-009769
SEC(opens sec.gov)
Feb 24
Frohlich Tom0001209191-23-006375
SEC(opens sec.gov)

Companies

Address

C/O JADE BIOSCIENCES, INC. 221 CRESCENT ST., BLDG. 23, STE. 105

WALTHAM, MA, 02453